Global Carcinoembryonic Antigen Market

Carcinoembryonic Antigen Market Size, Share, Growth Analysis, By Application(Colorectal Cancer Diagnosis, Breast Cancer Diagnosis), By End User(Hospitals, Diagnostic Laboratories), By Test Type(Blood Test, Immunohistochemistry) - Industry Forecast 2024-2031

Report ID: SQMIG35H2233 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 94 | Figures: 76

Carcinoembryonic Antigen Market News

  • December 2023: Sanofi is halting the worldwide scientific development initiative for tusamitamab ravtansine. This choice stems from the outcomes of a predetermined intervening time analysis of the Phase three CARMEN-LC03 trial, which assesses tusamitamab ravtansine as a monotherapy in opposition to docetaxel in previously treated patients with metastatic non-squamous non-small cellular lung cancer (NSCLC).
  • In May 2022, the University of Texas MD Anderson Cancer Center and Virogin Biotech announced a strategic collaboration to accelerate the development of investigational treatments, including oncolytic viruses and immunotherapies, for patients with advanced cancers.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Carcinoembryonic Antigen Market size was valued at USD 1.83 Billion in 2022 and is poised to grow from USD 1.98 Billion in 2023 to USD 2.63 Billion by 2031, at a CAGR of 4.10% during the forecast period (2024-2031)

The aggressive surroundings of the Carcinoembryonic Antigen marketplace is dynamic and is characterized by the presence of numerous key players actively shaping the enterprise dynamics. The enterprise leaders are continuously engaged in studies and improvement sports, aiming to innovate and introduce superior CEA checking out answers. Collaborations and strategic partnerships within the healthcare surroundings are not unusual techniques, fostering synergies for product improvement and market growth. 'Abbott Laboratories', 'Roche Diagnostics', 'Siemens Healthcare', 'Beckman Coulter', 'Ortho Clinical Diagnostics', 'Sysmex Corporation', 'Alere Inc.', 'bioMérieux', 'DiaSorin SpA', 'Quidel Corporation', 'Thermo Fisher Scientific', 'Hytest Ltd.', 'Luminex Corporation', 'Fujifilm Holdings Corporation', 'Danaher Corporation', 'PerkinElmer, Inc.', 'Bio-Rad Laboratories, Inc.', 'QIAGEN', 'Eurofins Scientific', 'Bio-Techne Corporation'

The growing incidence of most cancers, mainly colorectal cancers, has substantially augmented the call for dependable tumor markers like CEA. Early cancer detection and tracking, facilitated by using CEA checking out, are crucial factors using its adoption.

Rising Integration Of Advanced Technologies In Cea Testing Methodologies: The growing integration of superior technology in CEA testing methodologies. Continuous improvements in diagnostic technology, including the utility of novel immunoassays and improvements in biomarker discovery, are improving the precision and performance of CEA. Another tremendous fashion is the increasing scope of CEA packages past conventional most cancers diagnostics.

North America is probably to dominate the CEA marketplace. North America has a tremendously high incidence of colorectal cancer, that's a key utility for CEA testing. The vicinity's ageing population and way of life factors contribute to the prevalence of colorectal cancer. The properly-hooked up healthcare infrastructure in North America supports the adoption of superior diagnostic technology, which includes CEA checking out.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Cancer Monoclonal Antibodies Market
Buy Now GET FREE SAMPLE
Monoclonal Antibodies Market
Buy Now GET FREE SAMPLE
Medical Kiosk Market
Buy Now GET FREE SAMPLE
Men’s Health Supplements Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Carcinoembryonic Antigen Market

Product ID: SQMIG35H2233

$5,300
BUY NOW GET FREE SAMPLE